Delayed-release pharmaceutical formulations
The invention relates to a pharmaceutical delayed-release formulation containing proinsulin C-peptide and the use of the delayed-release formulations for treating of diabetes. In particular, the invention relates to delayed-release formulations in which proinsulin C-peptide is present in an absorbab...
Saved in:
| Main Authors | , |
|---|---|
| Format | Patent |
| Language | English |
| Published |
18.03.2004
|
| Online Access | Get full text |
Cover
Loading…
| Summary: | The invention relates to a pharmaceutical delayed-release formulation containing proinsulin C-peptide and the use of the delayed-release formulations for treating of diabetes. In particular, the invention relates to delayed-release formulations in which proinsulin C-peptide is present in an absorbable matrix consisting for example of absorbable polymers. The invention also relates to microparticles which contain proinsulin C-peptide. |
|---|